1) Sotalol hydrochloride
![点击朗读](/dictall/images/read.gif)
盐酸索他洛尔
1.
Synthesis of anti-arrhythmia drug Sotalol hydrochloride;
![点击朗读](/dictall/images/read.gif)
抗心律失常药盐酸索他洛尔的合成
2.
Determination of sotalol hydrochloride and sodium chloride injection by HPLC;
![点击朗读](/dictall/images/read.gif)
反相高效液相色谱法测定盐酸索他洛尔氯化钠注射液的含量
3.
In vitro drug release profiles and mucoadhesive property of sotalol hydrochloride bioadhesive microspheres
盐酸索他洛尔生物黏附微球的体外释药及黏附性能研究
2) Sotalol Hydrochloride Tablets
![点击朗读](/dictall/images/read.gif)
盐酸索他洛尔片
3) Sotalol hydrochloride injection
![点击朗读](/dictall/images/read.gif)
盐酸索他洛尔注射液
1.
Determination of the content and related substances in Sotalol hydrochloride injection by ion-pair HPLC;
离子对HPLC测定盐酸索他洛尔注射液的含量及有关物质
4) betaxolol hydrochloride
![点击朗读](/dictall/images/read.gif)
盐酸倍他洛尔
1.
Preparation of betaxolol hydrochloride-resin complexes and the in vitro drug release;
![点击朗读](/dictall/images/read.gif)
盐酸倍他洛尔药物树脂的制备及体外释药考察
2.
A capillary gas chromatographic method for determination of the residual amounts of acetone,isopropanol and toluene in betaxolol hydrochloride is reported.
采用毛细管气相色谱法对盐酸倍他洛尔原料药中丙酮、异丙醇及甲苯残留量进行测定。
5) betaxolol hydrochloride tablets
![点击朗读](/dictall/images/read.gif)
盐酸倍他洛尔片
1.
Pharmacokinetics and relative bioavailability of betaxolol hydrochloride tablets in Chinese healthy volunteers;
盐酸倍他洛尔片在健康人体的药代动力学和相对生物利用度
2.
UV analytical method on dissolution test of betaxolol hydrochloride tablets was developed,and the dissolution curve of the tablets were also studied.
建立了盐酸倍他洛尔片溶出度的UV测定方法,并研究了盐酸倍他洛尔片的溶出曲线。
6) Sotalol
['səutəlɔl]
![点击朗读](/dictall/images/read.gif)
索他洛尔
1.
Comparative Analysis and Its Clinical Significance of Sotalol and Propafenone on QT Dispersion;
索他洛尔和普罗帕酮对QT离散度的影响及其临床意义
2.
Clinical efficacy of low-dose Sotalol combined with Propafenone in patients with paroxysmal atrial fibrillatien;
索他洛尔联合普罗帕酮治疗阵发性房颤的效果观察
3.
A clinical study of sotalol in treating patients with ventricular premature beat;
![点击朗读](/dictall/images/read.gif)
索他洛尔治疗室性早搏的临床观察
补充资料:盐酸索他洛尔
分子式:C12H21ClN2O3S
分子量:暂无
CAS号:959-24-0
性质:暂无
制备方法:暂无
用途:β受体阻滞药。
分子量:暂无
CAS号:959-24-0
性质:暂无
制备方法:暂无
用途:β受体阻滞药。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条